Andon Health Co., Ltd. (SHE:002432)
China flag China · Delayed Price · Currency is CNY
68.46
+6.22 (9.99%)
Jul 31, 2026, 3:04 PM CST

Andon Health Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,1601,3662,5923,23126,3152,397
Revenue Growth
-50.36%-47.32%-19.77%-87.72%997.80%19.36%
Gross Profit
693.01842.211,8071,95620,7861,512
Operating Income
-354.7-324.28677.15752.6618,500919.31
Net Income
2,2942,2671,6691,25216,030908.64
Earnings Per Share
5.355.213.782.7734.302.00
EPS Growth
39.17%37.73%36.73%-91.93%1615.80%257.03%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Dec '23 Jan '23
Special Equipment Manufacturing Industry
1,1582,4393,09924.43
Internet Medical Products and Services
121.9876.1637.2117.88
New Retail Business
75.4762.9521.6832.27
Unallocated Other Income
9.8513.8560.2748.81
Total
1,3662,5923,23126,315

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
12,99511,57413,63611,38411,7601,343
Total Debt
6,5145,6823,3601,578317.75379.84
Net Cash (Debt)
6,4815,89210,2769,80611,443963.56
Net Cash Growth
-36.47%-42.66%4.79%-14.30%1087.52%15.94%
Net Cash Per Share
15.1113.5523.3021.6824.482.12

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-266.59-166.8986.751,77018,222293.11
Capital Expenditures
-314.52-264.33-73.92-212.65-211.9-70.45
Free Cash Flow
-581.12-431.13912.831,55718,010222.67
Free Cash Flow Growth
---41.39%-91.35%7988.15%-45.41%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
59.74%61.67%69.72%60.54%78.99%63.09%
Operating Margin
-30.58%-23.75%26.12%23.29%70.30%38.35%
Pretax Margin
224.95%185.07%81.28%48.91%69.38%41.70%
Profit Margin
197.75%165.99%64.38%38.74%60.92%37.91%
FCF Margin
-50.09%-31.57%35.22%48.20%68.44%9.29%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.6501.6500.2000.3002.5000.700
Dividend Per Share Growth
725.00%725.00%-33.33%-88.00%257.14%1066.67%
Dividend Yield
2.41%4.21%0.50%0.82%5.39%1.58%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
12.807.4211.2814.071.4525.45
Forward PE
-41.1741.1741.8623.66165.57
P/FCF Ratio
--20.6111.301.30103.86
PS Ratio
24.7512.317.265.450.899.65